Value of Neophotonics, Lumentum, and II-VI all slump after blacklisting order by US government.
US firm developing prostheses to restore level of sight to blind people will suspend production of older ‘Argus II’ product.
Yamagata-based Imuzak also develops optical elements based on moth-eye nanostructures.
Revenues, income and margins slide against previous year’s same quarter due to “seasonal softness and aggressive competition” in China.
Continued market weakness in automotive, lighting and mobile devices hits photonics giant, which announces remedial actions.
Sharp increase in sales and bookings from ‘Light and Production’ division keeps German firm on track despite weakness elsewhere.
Overall sales up but photonics segment down amid weak macroeconomic environment and microelectronics slowdown.
First full quarter since Oclaro acquisition, results include impact of restructure and costs related to shift in datacom strategy.
Sales and earnings up strongly again, thanks in part to the growing contribution of extreme ultraviolet optics.
UK-based epitaxial wafer foundry expecting two more customers to move to scale in next few weeks.
Leading edge of 5G network deployments and a strong uptick in bookings from China and India help fill the order book.
Newport and ESI businesses now benefiting from collective photonics expertise under the MKS umbrella.